Browsing byAuthorBell, KJL

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 18 of 18
Issue DateTitleAuthor(s)
2021-03-01A methods review of posttrial follow-up studies of cardiovascular prevention finds potential biases in estimating legacy effects.Zhu, L; Bell, KJL; Nayak, A; Hayen, A
2014-01-01Ambulatory blood pressure adds little to Framingham Risk Score for the primary prevention of cardiovascular disease in older men: Secondary analysis of observational study dataBell, KJL; Beller, E; Sundström, J; McGeechan, K; Hayen, A; Irwig, L; Neal, B; Glasziou, P
2017-01-17Change in bone mineral density is an indicator of treatment-related antifracture effectBell, KJL; Hayen, A; Glasziou, P; Irwig, L; Bauer, DC
2022-05-10Clinician views and experiences of non-invasive prenatal genetic screening tests in Australia.McKinn, S; Javid, N; Newson, AJ; Freeman, L; Bonner, C; Shand, AW; Nassar, N; Bell, KJL
2014-02-01Criteria for monitoring tests were described: Validity, responsiveness, detectability of long-term change, and practicalityBell, KJL; Glasziou, PP; Hayen, A; Irwig, L
2017-03EARLY CRT MONITORING USING TIME-DOMAIN OPTICAL COHERENCE TOMOGRAPHY DOES NOT ADD TO VISUAL ACUITY FOR PREDICTING VISUAL LOSS IN PATIENTS WITH CENTRAL RETINAL VEIN OCCLUSION TREATED WITH INTRAVITREAL RANIBIZUMAB: A Secondary Analysis of Trial Data.Bell, KJL; Hayen, A; Glasziou, P; Mitchell, AS; Farris, M; Wright, J; Duerr, H-P; Mitchell, P; Irwig, L
2019-01-01Erratum: Prognostic impact of systolic blood pressure variability in people with diabetes (PLoS ONE (2019) 13:4(e0194084)DOI:10.1371/journal.pone.0194084)Bell, KJL; Azizi, L; Nilsson, PM; Hayen, A; Irwig, L; Östgren, CJ; Sundström, J
2019-10-01Estimated legacy effects from simulated post-trial data were less biased than from combined trial/post-trial dataZhu, L; Bell, KJL; Hayen, A
2022-06-13Learning from the pandemic: mortality trends and seasonality of deaths in Australia in 2020.Gregory, G; Zhu, L; Hayen, A; Bell, KJL
2020-03-05Legacy effect of fibrate add-on therapy in diabetic patients with dyslipidemia: a secondary analysis of the ACCORDION study.Zhu, L; Hayen, A; Bell, KJL
2020-11Mammography screening for breast cancer-the UK Age trial.Bell, KJL; Irwig, L; Nickel, B; Hersch, J; Hayen, A; Barratt, A
2023-08Methods to address selection bias in post-trial studies of legacy effects were evaluated.Zhu, L; Bell, KJL; Hayen, A
2011-01-29Monitoring adherence to drug treatment by using change in cholesterol concentration: Secondary analysis of trial dataBell, KJL; Kirby, A; Hayen, A; Irwig, L; Glasziou, P
2011-12-10Optimizing the frequency of follow-up visits for patients treated for localized primary cutaneous melanomaTurner, RM; Bell, KJL; Morton, RL; Hayen, A; Francken, AB; Howard, K; Armstrong, B; Thompson, JF; Irwig, L
2012-01-01The potential value of monitoring bone turnover markers among women on alendronateBell, KJL; Hayen, A; Irwig, L; Hochberg, MC; Ensrud, KE; Cummings, SR; Bauer, DC
2018-04-01Prognostic impact of systolic blood pressure variability in people with diabetesBell, KJL; Azizi, L; Nilsson, PM; Hayen, A; Irwig, L; Östgren, CJ; Sundröm, J
2023-05Regular high-frequency whole blood donation and risk of cardiovascular disease in middle-aged and older blood donors in Australia.Karki, S; Bell, KJL; Hayen, A; Liu, B; Cust, AE; Olynyk, JK; Irving, DO
2013-05-04When to remeasure cardiovascular risk in untreated people at low and intermediate risk: Observational studyBell, KJL; Hayen, A; Irwig, L; Takahashi, O; Ohde, S; Glasziou, P